Literature DB >> 15716569

Attacking amyloid.

Jeffery W Kelly1.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15716569     DOI: 10.1056/NEJMcibr044231

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies.

Authors:  Xiaoling Wang; Tapan K Das; Satish K Singh; Sandeep Kumar
Journal:  MAbs       Date:  2009-05-29       Impact factor: 5.857

Review 2.  Towards revealing the structure of bacterial inclusion bodies.

Authors:  Lei Wang
Journal:  Prion       Date:  2009-07-25       Impact factor: 3.931

3.  Synthetic alpha-helix mimetics as agonists and antagonists of islet amyloid polypeptide aggregation.

Authors:  Ishu Saraogi; James A Hebda; Jorge Becerril; Lara A Estroff; Andrew D Miranker; Andrew D Hamilton
Journal:  Angew Chem Int Ed Engl       Date:  2010       Impact factor: 15.336

4.  Transthyretin Val30Met mutation in an African American with cardiac amyloidosis.

Authors:  P Christian Schulze; Mathew S Maurer
Journal:  Congest Heart Fail       Date:  2010 Mar-Apr

5.  Multidimensional structure-activity relationship of a protein in its aggregated states.

Authors:  Lei Wang; David Schubert; Michael R Sawaya; David Eisenberg; Roland Riek
Journal:  Angew Chem Int Ed Engl       Date:  2010-05-25       Impact factor: 15.336

6.  Current treatment in cardiac amyloidosis.

Authors:  Ivana Kholová; Josef Kautzner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

Review 7.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

Review 8.  Targeting Abeta and tau in Alzheimer's disease, an early interim report.

Authors:  Todd E Golde; Leonard Petrucelli; Jada Lewis
Journal:  Exp Neurol       Date:  2009-08-27       Impact factor: 5.330

9.  Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis.

Authors:  Li-Mei Yan; Marianna Tatarek-Nossol; Aleksandra Velkova; Athanasios Kazantzis; Aphrodite Kapurniotu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-07       Impact factor: 11.205

10.  Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila.

Authors:  Koichi Iijima; Hsueh-Cheng Chiang; Stephen A Hearn; Inessa Hakker; Anthony Gatt; Christopher Shenton; Linda Granger; Amy Leung; Kanae Iijima-Ando; Yi Zhong
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.